top of page

NEWSROOM

Search

Survival planning beyond social distancing

Surviving the unexpected

Adapting to politics and market disruptions

EAZE—SERVING 6 MILLION CUSTOMERS IN 100 CITIES IN SPITE OF COVID-19

Eaze’s innovative program is paving the way for a more equitable and inclusive future.

COVID-19, THE NEW NORMAL—AND A BETTER PATH

2020 YEAR OF THE SPAC

BIOTECH BOOMING DESPITE COVID-19 ECONOMY

MedMen’s Failure Is Everything Wrong With Legal Cannabis

AARP Magazine Features Eaze

Amivas Receives FDA Approval for Its Life-saving Treatment of Severe Malaria

Lavish Parties, Greedy Pols and Panic Rooms: How the ‘Apple of Pot’ Collapsed

Cowen raises $493M fund, further expanding biotech VC pot

MedTechFDA Authorizes Everlywell's Home Collection Kit For Use With Multiple COVID-19 Tests

LA’s New Coronavirus Testing Regime

FDA increases oversight, requirements for COVID-19 antibody tests

AstraZeneca vaults to the front of the Covid-19 vaccine race, teaming up to globalize Oxford candida

Pivotal Covid-19 study of remdesivir ‘met its primary endpoint,' is emergency authorization next?

Driven, Eaze Execs On Cannabis Sales Increases

MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market

bottom of page